The monthly membership includes: A new-patient evaluation with a provider, including labs (A1C, lipids, comprehensive metabolic panel, TSH, when indicated) A prescription for FDA-approved semaglutide (Wegovy) or tirzepatide (Zepbound) when clinically appropriate, billed through your pharmacy or, when feasible, the manufacturer's direct-pay channel Monthly follow-up visits to track weight, blood pressure, side effects, and dose titration Adjustments to other medications (blood pressure, diabetes, lipids) as your numbers improve A clear plan for what happens if you plateau, if side effects become a problem, or if your insurance changes A maintenance plan for after you hit your goal weight We don't promise quick fixes, before-and-after photos, or a specific number on the scale
Ready to harness these benefits
Independent replication of the key findings by groups outside the original laboratory has not been published, which is an additional concern for a compound with such dramatic claims
therefore, to achieve health benefits, the patient's individual needs must be considered ( According to IKDSG guidelines, KD use is strictly contraindicated in patients with a deficiency of carnitine (primary), carnitine palmitoyltransferase (CPT) 1 or 2, carnitine translocase, pyruvate carboxylase, medium-chain acyl-coenzyme A (CoA) dehydrogenase (MCAD), long-chain acyl-CoA dehydrogenase (LCAD), short-chain acyl-CoA dehydrogenase (SCAD), and disorders of fatty acid -oxidation and porphyria
